Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
Abstract
Hepatic fibrosis is a pathological lesion, characterized by the progressive accumulation of extracellular matrix (ECM) in the perisinusoidal space and it is a major problem in chronic liver diseases. Phenotypic activation of hepatic stellate cells (HSC) plays a central role in the progression of hepatic fibrosis. Retardation of proliferation and clearance of activated HSCs from the injured liver is an appropriate therapeutic strategy for the resolution and treatment of hepatic fibrosis. Clearance of activated HSCs from the injured liver by autophagy inhibitors, proapoptotic agents and senescence inducers with the high affinity toward the activated HSCs may be the novel therapeutic strategy for the treatment of hepatic fibrosis in the near future.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activated hepatic stellate cells are the major functional population during liver fibrogenesis.
“Activated hepatic stellate cells are the major functional population during liver fibrogenesis.154”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [154]
Cites
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · see citing works
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · see citing works
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · see citing works
Senescence of activated stellate cells limits liver fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.06.049 · Cited by 2,029 · see citing works
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,433 · see citing works
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · see citing works
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923 · see citing works
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870 · see citing works
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859 · see citing works
Hernández–Gea, V., Ghiassi–Nejad, Z., Rozenfeld, R., Gordon, R., Fiel, M. I., Yue, Z., Czaja, M. J., & Friedman, S. L. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.044 · Cited by 654 · see citing works
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Bisceglie, A. M. D., Shiffman, M. L., Everson, G. T., Lindsay, K. L., Everhart, J. E., Wright, E. C., Lee, W. M., Lok, A. S.-F., Bonkovsky, H. L., Morgan, T. R. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707615 · Cited by 462 · see citing works
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Kong, X., Feng, D., Wang, H., Hong, F., Bertola, A., Wang, F.-S., & Gao, B. (2012) · Hepatology · doi:10.1002/hep.25744 · Cited by 448 · see citing works
Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storage
Blaner, W. S., O'Byrne, S. M., Wongsiriroj, N., Kluwe, J., D'Ambrosio, D. M., Jiang, H., Schwabe, R. F., Hillman, E. M. C., Piantedosi, R., & Libien, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.11.001 · Cited by 444 · see citing works
A role for autophagy during hepatic stellate cell activation
Thoen, L. F. R., Guimarães, E. L. M., Dollé, L., Mannaerts, I., Najimi, M., Sokal, E., & van Grunsven, L. A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.010 · Cited by 385 · see citing works
Self-citation(2000) · PubMed · Cited by 371 · see citing works
Wright, M. C., Issa, R., Smart, D. E., Trim, N., Murray, G. I., Primrose, J. M., Arthur, M. J. P., Iredale, J. P., & Mann, D. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.27188 · Cited by 356 · see citing works
Purified Rat Liver Fat-Storing Cells in Culture Divide and Contain Collagen
Leeuw, A. D. M., McCarthy, S. P., Geerts, A. E., & Knook, D. L. (1984) · Hepatology · doi:10.1002/hep.1840040307 · Cited by 325 · see citing works
Reif, S. S., Lang, A., Lindquist, J. N., Yata, Y., Gäbele, E., Scanga, A. E., Brenner, D. A., & Rippe, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212927200 · Cited by 298 · see citing works
Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation
Iredale, J. P., Thompson, A., & Henderson, N. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.002 · Cited by 270 · see citing works
Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy
Hernández-Gea, V., Hilscher, M., Rozenfeld, R., Lim, M. P., Nieto, N., Werner, S., Devi, L. A., & Friedman, S. L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.016 · Cited by 236 · see citing works
Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224 · see citing works
Scraping fibrosis: Expressway to the core of fibrosis
Mehal, W. Z., Iredale, J. P., & Friedman, S. L. (2011) · Nature Medicine · doi:10.1038/nm0511-552 · Cited by 204 · see citing works
Parsons, C. J., Bradford, B. U., Pan, C. Q., Cheung, E., Schauer, M., Knorr, A., Krebs, B., Kraft, S., Zahn, S., Brocks, B., et al. (2004) · Hepatology · doi:10.1002/hep.20425 · Cited by 194 · see citing works
Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture
Mallat, A., Préaux, A.-M., Blazejewski, S., Rosenbaum, J., Dhumeaux, D., & Mavier, P. (1995) · Hepatology · doi:10.1002/hep.1840210418 · Cited by 180 · see citing works
Senescence in chronic liver disease: Is the future in aging?
Aravinthan, A. D., & Alexander, G. J. M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.030 · Cited by 174 · see citing works
NKp46-Mediated Killing of Human and Mouse Hepatic Stellate Cells Attenuates Liver Fibrosis
Gur, C., Doron, S., Kfir-Erenfeld, S., Horwitz, E., Abu-tair, L., Safadi, R., & Mandelboim, O. (2012) · Gut · doi:10.1136/gutjnl-2011-301400 · Cited by 173 · see citing works
IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner
Nishizawa, H., Iguchi, G., Fukuoka, H., Takahashi, M., Suda, K., Bando, H., Matsumoto, R., Yoshida, K., Odake, Y., Ogawa, W., et al. (2016) · Scientific Reports · doi:10.1038/srep34605 · Cited by 164 · see citing works
Natural killer and natural killer T cells in liver fibrosis
Gao, B., & Radaeva, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.008 · Cited by 158 · see citing works
Reversal of liver cirrhosis: current evidence and expectations
Jung, Y. K., & Yim, H. J. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.268 · Cited by 152 · see citing works
Jin, H., Lian, N., Zhang, F., Chen, L., Chen, Q., Lu, C., Bian, M., Shao, J., Wu, L., & Zheng, S. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.92 · Cited by 143 · see citing works
SOCS1 Links Cytokine Signaling to p53 and Senescence
Calabrese, V., Mallette, F. A., Deschênes‐Simard, X., Ramanathan, S., Gagnon, J., Moores, A., Ilangumaran, S., & Ferbeyre, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.044 · Cited by 141 · see citing works
Krämer, B., Körner, C., Kebschull, M., Glässner, A., Eisenhardt, M., Nischalke, H. D., Alexander, M., Sauerbruch, T., Spengler, U., & Nattermann, J. (2012) · Hepatology · doi:10.1002/hep.25804 · Cited by 129 · see citing works
The role of Stat5 transcription factors as tumor suppressors or oncogenes
Ferbeyre, G., & Moriggl, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.004 · Cited by 123 · see citing works
Duong, H. T. T., Dong, Z., Su, L. C., Boyer, C. A., George, J., Davis, T. P., & Wang, J. (2015) · Small · doi:10.1002/smll.201402870 · Cited by 120 · see citing works
Moles, A., Tarrats, N., Fernández-Checa, J. C., & Marı́, M. (2008) · Hepatology · doi:10.1002/hep.22753 · Cited by 105 · see citing works
Kinnman, N., Goria, O., Wendum, D., Gendron, M., Rey, C., Poupon, R. Y., & Housset, C. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780384 · Cited by 103 · see citing works
Shim, S. G., Jun, D. W., Kim, E., Saeed, W. K., Lee, K. N., Lee, H. L., Lee, O. Y., Choi, H. S., & Yoon, B. C. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12317 · Cited by 99 · see citing works
Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
Schon, H.-T., Bartneck, M., Borkham-Kamphorst, E., Nattermann, J., Lammers, T., Tacke, F., & Weiskirchen, R. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00033 · Cited by 97 · see citing works
Fernández, I., Meneu, J. C., Colina, F., García, I., Muñoz, R., Castellano, G., Fuertes, A., Abradelo, M., Lumbreras, C., Moreno, E., et al. (2006) · Liver Transplantation · doi:10.1002/lt.20883 · Cited by 93 · see citing works
Oxymatrine liposome attenuates hepatic fibrosisviatargeting hepatic stellate cells
Chai, N. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i31.4199 · Cited by 89 · see citing works
Liu, Y., Wen, X. M., Lui, E. L. H., Friedman, S. L., Cui, W., Ho, N. P. S., Li, L., Tao, Y., Fan, S. T., & Zhang, H. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.77 · Cited by 76 · see citing works
Zhang, Z., Guo, Y., Zhang, S., Zhang, Y., Wang, Y., Ni, W., Kong, D., Chen, W., & Zheng, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.042 · Cited by 57 · see citing works
Shaker, M. E., Ghani, A., Shiha, G. E.-S., Ibrahim, T. M., & Mehal, W. Z. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.02.033 · Cited by 55 · see citing works
Gallic Acid Induces Necroptosis via TNF–α Signaling Pathway in Activated Hepatic Stellate Cells
Chang, Y. J., Hsu, S. L., Liu, Y. T., Lin, Y., Lin, M. H., Huang, S. J., Ho, J. A., & Wu, L.-C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120713 · Cited by 54 · see citing works
Autophagy: A new therapeutic target for liver fibrosis
Mao, Y. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i16.1982 · Cited by 53 · see citing works
Kikuchi, A., Pradhan‐Sundd, T., Singh, S., Nagarajan, S., Loizos, N., & Monga, S. P. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.06.009 · Cited by 53 · see citing works
Kong, D., Zhang, F., Zhang, Z., Lu, Y., & Zheng, S. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2012.10.002 · Cited by 47 · see citing works
Chen, J., Xu, T., Zhu, D., Wang, J., Huang, C., Lyu, L., Hu, B., Sun, W., & Duan, Y. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.228 · Cited by 47 · see citing works
Hao, H., Zhang, D., Shi, J., Wang, Y., Chen, L., Guo, Y., Ma, J., Jiang, X., & Jiang, H. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000316 · Cited by 46 · see citing works
Ezhilarasan, D., Evraerts, J., Sid, B., Calderón, P. B., Karthikeyan, S., Sokal, E. M., & Najimi, M. (2017) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60166-2 · Cited by 43 · see citing works
Self-citationSilibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells
Ezhilarasan, D., Evraerts, J., Sid, B., Calderón, P. B., Karthikeyan, S., Sokal, E. M., & Najimi, M. (2016) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2016.01.002 · Cited by 41 · see citing works
Self-citationKim, I. H., Kim, S. W., Kim, S., Lee, S. O., Lee, S. T., Kim, D. G., Lee, M. J., & Park, W. H. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.7.051 · Cited by 38 · see citing works
New therapies for hepatic fibrosis
Koyama, Y., & Brenner, D. A. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.06.011 · Cited by 37 · see citing works
Zhao, J., Peng, L., Cui, R., Guo, X., & Yan, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.010 · Cited by 37 · see citing works
Lee, P., Woo, S., Jee, J., Sung, S. H., & Kim, H. (2015) · Molecules · doi:10.3390/molecules20011277 · Cited by 36 · see citing works
Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL
Xu, F., Zhou, D., Meng, X., Wang, X., Liu, C., Huang, C., Li, J., & Zhang, L. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.013 · Cited by 36 · see citing works
Cheng, C., & Pan, T. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03700 · Cited by 35 · see citing works
Huang, L., Xie, J., Bi, Q., Li, Z., Liu, S., Shen, Q., & Li, C. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01174 · Cited by 35 · see citing works
Feng, Q. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i34.9900 · Cited by 32 · see citing works
Seo, H.-Y., Jang, B. K., Jung, Y., Lee, E.-J., Kim, H.-S., Jeon, J., Kim, J.-G., Lee, I.-K., Kim, M.-K., & Park, K.-G. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.149 · Cited by 31 · see citing works
Safer, A.-M., Hanafy, N. A. N., Bharali, D. J., Cui, H., & Mousa, S. A. (2015) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2015.10608 · Cited by 23 · see citing works
Zhang, J., WANG, M., ZHANG, Z., Luo, Z., Liu, F., & Liu, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3048 · Cited by 21 · see citing works
Sasaki, R., Kanda, T., Nakamura, M., Nakamoto, S., Haga, Y., Wu, S., Shirasawa, H., & Yokosuka, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146314 · Cited by 20 · see citing works
Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation
Wang, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i27.8326 · Cited by 20 · see citing works
Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis
Yu, F., Teng, Y., Zhu, Q., Zhang, Q., & Tang, Y. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0036 · Cited by 17 · see citing works
Liu, M., He, Y., & Zhang, J. (2013) · PubMed · Cited by 14 · see citing works
Mycophenolic acid induces apoptosis of hepatic stellate cells in an in vitro model of HCV
Best, J., Zahn, A., Beilfuss, A., Sydor, S., Fingas, C. D., Sowa, J., Anastasiou, O. E., Cicinnati, V. R., Gerken, G., Canbay, A. E., et al. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31280-3 · Cited by 3 · see citing works
Flagged first, then by citations
3 of the 71 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Inflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443 · see citing works
“Activated hepatic stellate cells are the major functional population during liver fibrogenesis.(154) During senescence, their replication, immunerecruiting signals, and clearance are important for the regulation of liver fibrogenesis.”
BackgroundEzhilarasan, D. (2021) · Toxicology · doi:10.1016/j.tox.2021.152840 · Cited by 177 · see citing works
Self-citationFerroptosis and Liver Fibrosis
Pan, Q., Luo, Y., Xia, Q., & He, K. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.62903 · Cited by 154 · see citing works
MicroRNA interplay between hepatic stellate cell quiescence and activation
Ezhilarasan, D. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173507 · Cited by 129 · see citing works
Self-citationRegulation of cellular senescence by extracellular matrix during chronic fibrotic diseases
Blokland, K. E. C., Pouwels, S. D., Schuliga, M. J., Knight, D. A., & Burgess, J. K. (2020) · Clinical Science · doi:10.1042/cs20190893 · Cited by 129 · see citing works
Human biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117 · see citing works
Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models
Ezhilarasan, D. (2023) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2023.104093 · Cited by 107 · see citing works
Self-citationCritical role of estrogen in the progression of chronic liver diseases
Ezhilarasan, D. (2020) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/j.hbpd.2020.03.011 · Cited by 96 · see citing works
Self-citationYan, L., Lu, Y., & Li, X. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1641508 · Cited by 96 · see citing works
Zhuang, T., Gu, X., Zhou, N., Ding, L., Yang, L., & Zhou, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110224 · Cited by 77 · see citing works
Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
Ezhilarasan, D. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30582 · Cited by 77 · see citing works
Self-citationEzhilarasan, D., Roy, A., Veeraragavan, G. R., Magesh, A., Sleeba, A. V., Arivarasu, L., & Brundha, M. P. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01810-8 · Cited by 72 · see citing works
Self-citationDu, Z., Wu, T., Liu, L., Luo, B., & Wei, C. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16119 · Cited by 71 · see citing works
Sestrin2: multifaceted functions, molecular basis, and its implications in liver diseases
Lu, C., Jiang, Y., Xu, W., & Bao, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05669-4 · Cited by 72 · see citing works
Liver fibrosis: Extracellular vesicles mediated intercellular communication in perisinusoidal space
Ezhilarasan, D., Perumal, E., Raghunandhakumar, S., & Najimi, M. (2021) · Hepatology · doi:10.1002/hep.32239 · Cited by 63 · see citing works
Self-citationAnti-fibrotic treatments for chronic liver diseases: The present and the future
Odagiri, N., Matsubara, T., Sato-Matsubara, M., Fujii, H., Enomoto, M., & Kawada, N. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0187 · Cited by 63 · see citing works
Nanotechnology in Drug Delivery for Liver Fibrosis
Gu, L., Zhang, F., Wu, J., & Zhuge, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.804396 · Cited by 61 · see citing works
Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells
Ezhilarasan, D. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220949148 · Cited by 52 · see citing works
Self-citationEzhilarasan, D. (2021) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/j.hbpd.2021.04.010 · Cited by 39 · see citing works
Self-citationAntitubercular drugs induced liver injury: an updated insight into molecular mechanisms
Ezhilarasan, D. (2023) · Drug Metabolism Reviews · doi:10.1080/03602532.2023.2215478 · Cited by 43 · see citing works
Self-citationWu, Z., Ma, Y., Gong, X., Zhang, Y., Zhao, L., Cheng, G., & Cai, S. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103498 · Cited by 43 · see citing works
Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases
Udomsinprasert, W., Sobhonslidsuk, A., Jittikoon, J., Honsawek, S., & Chaikledkaew, U. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992385 · Cited by 40 · see citing works
H3K18 lactylation accelerates liver fibrosis progression through facilitating SOX9 transcription.
Wu, S., Li, J., & Zhan, Y.-T. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114135 · Cited by 42 · see citing works
Li, Z.-B., Jiang, L., Ni, J., Xu, Y.-H., Liu, F., Liu, W., Wang, S.-G., Liu, Z., & Wang, C.-Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01044-9 · Cited by 36 · see citing works
Ban, D., Hua, S., Zhang, W., Shen, C., Miao, X., & Liu, W. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0179-4 · Cited by 36 · see citing works
Zhang, S.-L., Ma, L., Zhao, J., You, S., Ma, X., Ye, X., & Liu, T. (2019) · Molecules · doi:10.3390/molecules24183282 · Cited by 35 · see citing works
S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma
Delangre, E., Oppliger, E., Berkcan, S., Gjorgjieva, M., de Sousa, M. C., & Foti, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911030 · Cited by 34 · see citing works
Evaluation of Pancreatic Fibrosis Grading by Multiparametric Quantitative Magnetic Resonance Imaging
Liu, C., Shi, Y., Lan, G., Xu, Y., & Yang, F. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27626 · Cited by 33 · see citing works
Sequential delivery for hepatic fibrosis treatment based on carvedilol loaded star-like nanozyme
Lü, Q., Zhou, Y., Xu, M., Liang, X., Jing, H., Wang, X., & Li, N. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.033 · Cited by 32 · see citing works
Siapoush, S., Rezaei, R., Alavifard, H., Hatami, B., Zali, M. R., Vosough, M., Lorzadeh, S., Łoś, M., Baghaei, K., & Ghavami, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121894 · Cited by 32 · see citing works
Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
Hofschröer, V., Najder, K., Rugi, M., Bouazzi, R., Cozzolino, M., Arcangeli, A., Panyi, G., & Schwab, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.586599 · Cited by 31 · see citing works
Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
Sotoudeheian, M. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665301698240404061300 · Cited by 32 · see citing works
Jiang, Y., Hou, L., Dou, J., Xuan, M., Cui, Z., Lian, L., Nan, J., & Wu, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155145 · Cited by 29 · see citing works
Antifibrotic effect of methylated quercetin derivatives on TGFβ-induced hepatic stellate cells
Ganbold, M., Shimamoto, Y., Ferdousi, F., Tominaga, K., & Isoda, H. (2019) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2019.100678 · Cited by 28 · see citing works
Li, X., Chen, R., Kemper, S., & Brigstock, D. R. (2020) · Cells · doi:10.3390/cells9020290 · Cited by 28 · see citing works
Wang, T., Zhou, X., Kuang, G., Jiang, R., Guo, X., Wu, S., Wan, J., & Yin, L. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa042 · Cited by 28 · see citing works
Shenoy, A. D., Rajaraman, V., & Maiti, S. (2022) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_119_22 · Cited by 27 · see citing works
Jin, X., Fu, B., Wu, Z., Zheng, X., Hu, J., Jin, L., & Tang, L. (2020) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2020.05.009 · Cited by 26 · see citing works
Sun, C., Shi, C., Duan, X., Zhang, Y., & Wang, B. (2022) · Bioengineered · doi:10.1080/21655979.2021.2023799 · Cited by 25 · see citing works
Feng, Y., Li, Y., Xu, M., Meng, H., Dai, C., Yao, Z., & Lin, N. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03069-7 · Cited by 25 · see citing works
Abu-Risha, S. E.-S., Sokar, S. S., Elbohoty, H. R., & El‐Sisi, A. E. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109750 · Cited by 26 · see citing works
Light-triggered NO-releasing nanoparticles for treating mice with liver fibrosis
Liang, H., Li, Z., Ren, Z., Jia, Q., Guo, L., Li, S., Zhang, H., Hu, S., Zhu, D., Shen, D., et al. (2020) · Nano Research · doi:10.1007/s12274-020-2833-6 · Cited by 25 · see citing works
Irisin Regulates the Functions of Hepatic Stellate Cells
Dong, H. N., Park, S. Y., Le, C. T., Choi, D.-H., & Cho, E.-H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.658 · Cited by 23 · see citing works
Shu, Y., Liu, X., Huang, H., Wen, Q., & Shu, J. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06171-w · Cited by 23 · see citing works
Wang, A., Bu, F., Li, J., Zhang, Y., Jia, P., You, H., Wu, S., Wu, Y., Zhu, S., Huang, C. Z., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.11.014 · Cited by 23 · see citing works
Wang, L., Zhang, L., Jiang, B., Zhao, K., Zhang, Y., & Xie, X. (2022) · British Journal of Radiology · doi:10.1259/bjr.20211136 · Cited by 23 · see citing works
Advantages and challenges in nanomedicines for chronic liver diseases: A hepatologist's perspectives
Ezhilarasan, D. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173832 · Cited by 22 · see citing works
Self-citationInteraction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review)
Cheng, Q.-N., Yang, X. Y., Wu, J., Ai, W., & Ni, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12003 · Cited by 22 · see citing works
Possible roles of Golgi protein-73 in liver diseases
Liu, M., Huang, L. H., Wu, J., Zhang, H., Ai, W., & Zhang, R. (2022) · Annals of Hepatology · doi:10.1016/j.aohep.2022.100720 · Cited by 22 · see citing works
Relaxin in hepatic fibrosis: What is known and where to head?
Ezhilarasan, D. (2021) · Biochimie · doi:10.1016/j.biochi.2021.06.001 · Cited by 21 · see citing works
Self-citationBuchl, S. C., Hanquier, Z., Haak, A. J., Thomason, Y. M., Huebert, R. C., Shah, V. H., & Maiers, J. L. (2021) · Hepatology Communications · doi:10.1002/hep4.1835 · Cited by 20 · see citing works
α-Lipoic acid modulates liver fibrosis: A cross talk between TGF-β1, autophagy, and apoptosis
El-Maadawy, W. H., Hammam, O. A., el-Din, S. H. S., & El-Lakkany, N. M. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119891212 · Cited by 19 · see citing works
Preclinical liver toxicity models: Advantages, limitations and recommendations
Ezhilarasan, D., Karthikeyan, S., Najimi, M., Paramasivan, V., Bhavani, G., & Rani, M. J. (2024) · Toxicology · doi:10.1016/j.tox.2024.154020 · Cited by 19 · see citing works
Self-citationRetinoids in Stellate Cells: Development, Repair, and Regeneration
Carmona, R., Barrena, S., & Muñoz‐Chápuli, R. (2019) · Journal of Developmental Biology · doi:10.3390/jdb7020010 · Cited by 18 · see citing works
Liu, X., Li, D., Li, T. Y., Wu, Y., Piao, J. S., & Piao, M. G. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106189 · Cited by 18 · see citing works
Xiu, M.-X., Zhao, Y., Wang, X., Yuan, S., Qin, B.-F., Sun, J., Cui, L., & Song, J. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2022.151989 · Cited by 19 · see citing works
Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver
Ezhilarasan, D. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.30956 · Cited by 18 · see citing works
Self-citationQin, L., Tan, J., Lv, X., & Zhang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115673 · Cited by 18 · see citing works
Bestion, E., Jílková, Z. M., Mège, J., Novello, M., Kurma, K., Pour, S. T. A., Lalmanach, G., Vanderlynden, L., Fizanne, L., Bassissi, F., et al. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320942042 · Cited by 18 · see citing works
Metabolic Alterations in Spheroid-Cultured Hepatic Stellate Cells
Fujisawa, K., Takami, T., Sasai, N., Matsumoto, T., Yamamoto, N., & Sakaida, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103451 · Cited by 18 · see citing works
Ezhilarasan, D., & Najimi, M. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103902 · Cited by 17 · see citing works
Self-citationYang, Z., Zhang, L., Zhu, H. H., Zhou, K., Wang, H., Wang, Y., Su, R., Guo, D., Zhou, L., Xu, X., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16434 · Cited by 17 · see citing works
Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD
Ezhilarasan, D., & Kulanthaivel, L. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4112 · Cited by 17 · see citing works
Self-citationVaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway
Abdolahi, A., Vahabzadeh, Z., Izadpanah, E., & Moloudi, M. R. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00852-7 · Cited by 16 · see citing works
Huang, H., & Deng, Z. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.147 · Cited by 16 · see citing works
Zhang, Y., Cai, B., Li, Y., Xu, Y. J., Wang, Y., Zheng, L., Zheng, X., Yin, L., Chen, G., Wang, Y., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1098463 · Cited by 15 · see citing works
Role of sirtuins in liver diseases
Ezhilarasan, D., & Najimi, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814118-2.00005-7 · Cited by 15 · see citing works
Self-citationZhou, J., Lan, Q., Li, W., Yang, L., You, J., Zhang, Y., & Ni, W. (2019) · Cell Biology International · doi:10.1002/cbin.11206 · Cited by 15 · see citing works
Le, T. V., Dinh, N. B. T., Dang, T. M., Phan, N. L.-C., Dang, L. T. T., Grassi, G., Holterman, A., Le, H. M., & Truong, N. H. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15726 · Cited by 14 · see citing works
Estrogen receptor 1 signaling in hepatic stellate cells designates resistance to liver fibrosis
Li, T., Wang, G., Zhao, H., Liu, F., Deng, Z., Chen, D., Zhou, X., Cao, Y., Fu, W., Zhang, H., et al. (2025) · Cell Discovery · doi:10.1038/s41421-025-00783-3 · Cited by 13 · see citing works
Tao, H., Liu, Q., Zeng, A., & Song, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110497 · Cited by 13 · see citing works
Hanquier, Z., Misra, J., Baxter, R., & Maiers, J. L. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.06.006 · Cited by 13 · see citing works
Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
Harini, K. S., & Ezhilarasan, D. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105467 · Cited by 13 · see citing works
Self-citationDing, R., Zheng, J., Li, N., Cheng, Q., Zhu, M., Wang, Y., Zhou, X., Zhang, Z., & Shi, G. (2021) · PeerJ · doi:10.7717/peerj.11374 · Cited by 13 · see citing works
Role of ferroptosis in fibrosis diseases
Sun, Z., Zou, X., Bao, M., Huang, Z., Lou, Y., Zhang, Y., & Huang, P. C. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.04.024 · Cited by 14 · see citing works
Lin, Y., Xue, T., Su, X., Liu, Z., Liu, H., Tan, Z., Gan, C., Xie, Y., & Ye, T. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114685 · Cited by 12 · see citing works
CaM/CaMKII mediates activation and proliferation of hepatic stellate cells regulated by ASIC1a
Liu, H., Lu, W., Hong, H.-Q., Li, M., Ye, M.-P., Rao, Q.-F., Kong, J.-L., Luan, S., Huang, Y., Hu, Q., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.996667 · Cited by 12 · see citing works
Li, T., Su, X., Chen, L.-L., Zhang, W., Zhang, J., Wang, Y., & Xu, W. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109527 · Cited by 12 · see citing works
Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis
Setyawati, D. R., Sekaringtyas, F. C., Pratiwi, R. D., Rosyidah, A., Azhar, R., Gustini, N., Syahputra, G., Rosidah, I., Mardliyati, E., Tarwadi, et al. (2024) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.15.89 · Cited by 12 · see citing works
Lead compounds with the potentials for the treatment of chronic liver diseases
Ezhilarasan, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817890-4.00012-3 · Cited by 12 · see citing works
Self-citationNanomedicine for Hepatic Fibrosis
Ezhilarasan, D., & Rajeshkumar, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-0391-7_2 · Cited by 12 · see citing works
Self-citationTian, T., Xie, R., Ding, K., Han, B., Yang, Q., & Yang, X. Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9611 · Cited by 11 · see citing works
Yuan, W., Qiu, T., Yao, X., Wu, C., Shi, Y., Wang, N., Zhang, J., Jiang, L., Liu, X., Yang, G., et al. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.07.816 · Cited by 11 · see citing works
UEG Week 2019 Poster Presentations
Jaeger, M.-C., Guiraud, L., Rolland, C., Rolland, C., Belot, A., Sebbag, M., Bermúdez‐Humarán, L. G., Langella, P., Vergnolle, N., & Deraison, C. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619854671 · Cited by 11 · see citing works
Chen, T., Zuo, X., Wang, S., Yu, P., Yuan, J., Wei, S., Chen, J., Sun, Y., Gao, Y., & Li, X. (2020) · Medicine · doi:10.1097/md.0000000000020296 · Cited by 9 · see citing works
Sungkar, T., Putra, A. B., Lindarto, D., & Sembiring, R. J. (2020) · Medicinski Glasnik · doi:10.17392/1211-21 · Cited by 9 · see citing works
Singh, T. R., & Ezhilarasan, D. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.1945079 · Cited by 9 · see citing works
Self-citationXiao, W., Lu, M.-H., Rong, P., Zhang, H., Gong, J., Peng, Y., Gong, H., & Liu, Z. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11423 · Cited by 8 · see citing works
Ma, H., Wang, X., Liu, X., Wang, C., Gao, X., & Niu, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.841248 · Cited by 8 · see citing works
Noufal, Z. M., Sivaperumal, P., & Elumalai, P. (2022) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_331_22 · Cited by 8 · see citing works
The potential health benefits and mechanisms of sesame lignans in age-related diseases
Li, Y., Chang, Y., Zhang, Y., Tu, W., Xu, F., Zhang, L., Wang, X., & Wang, L. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105360 · Cited by 7 · see citing works
Yang, R., Zhu, J., Jin, X., Li, Y., Wang, D., & Chao, J. (2025) · Toxicology · doi:10.1016/j.tox.2025.154359 · Cited by 9 · see citing works
Chen, Y., Lin, L., Yang, C., Li, T., Li, Y., Wang, J., Wu, Y., Zhao, Y., & Su, G. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06804 · Cited by 7 · see citing works
Fan, J., Luo, N., Liu, G.-F., Xu, X., Li, S., & Lv, X. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i22.3422 · Cited by 7 · see citing works
Ye, Z., Huang, Q., She, Y., Hu, Y., Wu, M., Qin, K., Li, L., Zhang, C., Zuo, X., Wei, A., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.920062 · Cited by 7 · see citing works
HO‐1: An emerging target in fibrosis
Lu, C., Liu, Y., Ren, F., Zhang, H., Hou, Y., Zhang, H., Chen, Z., & Du, X. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31465 · Cited by 6 · see citing works
New advances of nanozymes for the diagnosis and treatment of digestive system diseases (Review)
Xie, D., Xie, L., Fang, C., Du, Z., Cao, Z., Su, C., & Huo, Y. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5617 · Cited by 6 · see citing works
Wei, W., Lin, C., Luo, S., Huang, J., Hu, R.-T., Li, J., Ma, H., Wei, J.-Z., Wang, C., Lim, C.-S.-Y., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152703 · Cited by 6 · see citing works
Chen, Y., Zhao, Y., Yuan, L., He, Y., Yang, Y., & Xiao, P. (2023) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.94457 · Cited by 6 · see citing works
Deciphering the toxicological role of Porphyromonas gingivalis derived endotoxins in liver diseases
Ezhilarasan, D. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103755 · Cited by 6 · see citing works
Self-citation
- Authors
- Ezhilarasan, D., Sokal, E., & Najimi, M.
- Affiliations
- Saveetha University (IN)
- UCLouvain (BE)
- Corresponding author
- Ezhilarasan, Devaraj
- Venue
- Hepatobiliary & Pancreatic Diseases International
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 17
- Issue
- 3
- Pages
- 192-197
- ISSN
- 2352-9377 (ISSN-L)
- 1499-3872
- OpenAlex
- W2802633545
- Cited by
- 204
- References
- 71
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 16 · 2023: 27 · 2022: 28 · 2021: 64 · 2020: 32 · 2019: 10 · 2012: 1
- FWCI
- 16.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatobiliary & pancreatic diseases international (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cells, hepatic stellate cell activation, extracellular matrix accumulation, chronic liver disease, autophagy inhibitors, cellular senescence, antifibrotic therapy
- MeSH terms
- Animals, Autophagy, Extracellular Matrix, Humans, Liver, Liver Cirrhosis, Phenotype, Signal Transduction, Cellular Senescence, Apoptosis, Cell Proliferation, Hepatic Stellate Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review